Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mari L DeMarco

Showing results (31-40 of 74) with videos related to

Pageof 8
Sort By:
Journal of Neuroscience Methods|September 1, 2021
Aptamer-based enrichment of TDP-43 from human cells and tissues with quantification by HPLC-MS/MSTaylor D Pobran, David Yang, Ian R A Mackenzie, et al.
Clinical Chemistry and Laboratory Medicine|December 9, 2021
Establishing pre-analytical requirements and maximizing peptide recovery in the analytical phase for mass spectrometric quantification of amyloid-β peptides 1-42 and 1-40 in CSFLauren M Forgrave, J Grace van der Gugten, Quyen Nguyen, et al.
American Journal of Respiratory and Critical Care Medicine|July 16, 2015
Biomarker Development for Chronic Obstructive Pulmonary Disease. From Discovery to Clinical ImplementationDon D Sin, Zsuzsanna Hollander, Mari L DeMarco, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|July 4, 2020
An automated clinical mass spectrometric method for identification and quantification of variant and wild-type amyloid-β 1-40 and 1-42 peptides in CSFMari L DeMarco, Quyen Nguyen, Alice Fok, et al.
Chest|October 4, 2016
Biomarker Development in COPD: Moving From P Values to Products to Impact Patient CareZsuzsanna Hollander, Mari L DeMarco, Mohsen Sadatsafavi, et al.
Canadian Journal of Gastroenterology & Hepatology|December 14, 2016
The Utility of Infliximab Therapeutic Drug Monitoring among Patients with Inflammatory Bowel Disease and Concerns for Loss of Response: A Retrospective Analysis of a Real-World ExperienceRobert A Mitchell, Constantin Shuster, Neal Shahidi, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2025
BiomarkersDurjoy Lahiri, Jennifer G Cooper, Bruna Seixas Lima, et al.
Clinical Chemistry|January 21, 2018
Resolution of Spurious Immunonephelometric IgG Subclass Measurement Discrepancies by LC-MS/MSGrace van der Gugten, Mari L DeMarco, Luke Y C Chen, et al.
Clinical Mass Spectrometry (Del Mar, Calif.)|December 17, 2021
Detection and characterization of TDP-43 in human cells and tissues by multiple reaction monitoring mass spectrometryTaylor D Pobran, Lauren M Forgrave, Yu Zi Zheng, et al.
Clinical Chemistry|October 2, 2019
An Intact ACTH LC-MS/MS Assay as an Arbiter of Clinically Discordant Immunoassay ResultsJunyan Shi, Pawan Dhaliwal, Yu Zi Zheng, et al.
Pageof 8

Showing results (31-40 of 74) with videos related to

Sort By:
Pageof 8
Journal of Neuroscience Methods|September 1, 2021
Aptamer-based enrichment of TDP-43 from human cells and tissues with quantification by HPLC-MS/MSTaylor D Pobran, David Yang, Ian R A Mackenzie, et al.
Clinical Chemistry and Laboratory Medicine|December 9, 2021
Establishing pre-analytical requirements and maximizing peptide recovery in the analytical phase for mass spectrometric quantification of amyloid-β peptides 1-42 and 1-40 in CSFLauren M Forgrave, J Grace van der Gugten, Quyen Nguyen, et al.
American Journal of Respiratory and Critical Care Medicine|July 16, 2015
Biomarker Development for Chronic Obstructive Pulmonary Disease. From Discovery to Clinical ImplementationDon D Sin, Zsuzsanna Hollander, Mari L DeMarco, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|July 4, 2020
An automated clinical mass spectrometric method for identification and quantification of variant and wild-type amyloid-β 1-40 and 1-42 peptides in CSFMari L DeMarco, Quyen Nguyen, Alice Fok, et al.
Chest|October 4, 2016
Biomarker Development in COPD: Moving From P Values to Products to Impact Patient CareZsuzsanna Hollander, Mari L DeMarco, Mohsen Sadatsafavi, et al.
Canadian Journal of Gastroenterology & Hepatology|December 14, 2016
The Utility of Infliximab Therapeutic Drug Monitoring among Patients with Inflammatory Bowel Disease and Concerns for Loss of Response: A Retrospective Analysis of a Real-World ExperienceRobert A Mitchell, Constantin Shuster, Neal Shahidi, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2025
BiomarkersDurjoy Lahiri, Jennifer G Cooper, Bruna Seixas Lima, et al.
Clinical Chemistry|January 21, 2018
Resolution of Spurious Immunonephelometric IgG Subclass Measurement Discrepancies by LC-MS/MSGrace van der Gugten, Mari L DeMarco, Luke Y C Chen, et al.
Clinical Mass Spectrometry (Del Mar, Calif.)|December 17, 2021
Detection and characterization of TDP-43 in human cells and tissues by multiple reaction monitoring mass spectrometryTaylor D Pobran, Lauren M Forgrave, Yu Zi Zheng, et al.
Clinical Chemistry|October 2, 2019
An Intact ACTH LC-MS/MS Assay as an Arbiter of Clinically Discordant Immunoassay ResultsJunyan Shi, Pawan Dhaliwal, Yu Zi Zheng, et al.
Pageof 8